4
Changes in Ownership
GENELUX Corp Filed Acc 0001415889-24-019343
VP, Clinical Trial Operations sold 6,849 shares at $2.12 ($14,520)
- VP, Clinical Trial Operations acquired 15,218 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/form4-07082024_040709.xml…